TORONTO, ONTARIO--(Marketwired - Dec. 19, 2016) - Vodis Pharmaceuticals Inc. has announced a consolidation of its issued and outstanding share capital on the basis of one (1) post consolidation share for each four (4) pre-consolidation common shares. No fractional shares will be issued. Any fraction of a share will be rounded down to the nearest whole number.
As a result, the outstanding shares of the company will be reduced to approximately 28,460,645.
The shares will begin trading on a consolidated basis and with a new CUSIP number on December 21, 2016.
The name and symbol will not change.
Please note that all open orders will be cancelled at the end of business on December 20, 2016. Dealers are reminded to re-enter their orders taking into account the share consolidation.
| Trading on a Consolidated Basis: | December 21, 2016 |
| Record Date: | December 23, 2016 |
| NEW CUSIP: | 92858L202 |
| NEW ISIN: | CA92858L2021 |
Contact Information:
Listings
(416) 367-7340
Listings@thecse.com
www.thecse.com